Warner Chilcott Waives Exclusivity Agreement On Oral Contraceptive Ovcon 35; Barr Announces It Will Produce Generic Version Of Drug
Mon, 02 Oct 2006 01:00 PM EST
... Hamilton, Bermuda-based pharmaceutical company Warner Chilcott on Monday waived an exclusivity agreement that required Barr Pharmaceuticals to supply only to Warner the oral contraceptive Ovcon 35, and Barr on Tuesday announced its subsidiary Barr Laboratories would produce a generic version of the drug to sell in the U.S., the AP/MSN Money reports. [click link for full article] ...
Related Topics
- Ethinyl Estradiol and Norethindrone (Oral Contraceptive)
- Epstein Barr Virus
- Risedronate
- Ethinyl Estradiol and Ethynodiol Diacetate
- Drug Safety
- Prescription Drugs
- Importation
- Lp(a)
- Drug Side Effects
- Sumatriptan Oral
- Oral Cancer
- Phendimetrazine
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Oral Health
- Triamterene and Hydrochlorothiazide
- Frequent infections especially with Epstein-Barr virus
- Epstein-Barr Virus (EBV) Infection

Not Signed In -

